Icare Versus Haag-Streit Applanation Tonometer
Launched by ICARE FINLAND OY · Jul 8, 2010
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects were eligible for the study if they had no exclusion criteria as specified by the ANSI/ISO standard
- Subjects were selected according to the following exclusion criteria (as given in ANSI Z80.10-2003 and ISO 8612):
- • subjects with only one functional eye
- • those with one eye having poor or eccentric fixation
- • high corneal astigmatism (i.e. those eyes displaying an oval contact image with the Goldmann tonometer)
- • those with corneal scarring or who have had corneal surgery, including corneal laser surgery
- • microphthalmos
- • buphthalmos
- • contact lens wearers
- • dry eyes
- • lid squeezers (blepharospasm)
- • nystagmus
- • keratoconus
- • any other corneal or conjunctival pathology or infection
About Icare Finland Oy
icare Finland Oy is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative solutions. With a strong focus on ethical standards and regulatory compliance, the organization collaborates closely with healthcare professionals and research institutions to design and execute high-quality clinical studies. Leveraging its expertise in various therapeutic areas, icare Finland Oy aims to facilitate the development of new therapies and medical technologies, ultimately enhancing the quality of care for patients globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Trial Officials
Päivi Puska, MD, FEBO
Principal Investigator
Helsinki University Central Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials